France-based Nicox SA has secured €18 million in fresh capital to finance further studies of its investigational ophthalmology compounds, giving it a cash runway to pursue its ambition to be a player in the US market for eye-care products. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
